These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 35761500)
1. Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand? Tallarico M; Pisano M; Leo A; Russo E; Citraro R; De Sarro G Curr Neuropharmacol; 2023; 21(8):1691-1713. PubMed ID: 35761500 [TBL] [Abstract][Full Text] [Related]
3. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Cardamone L; Salzberg MR; O'Brien TJ; Jones NC Br J Pharmacol; 2013 Apr; 168(7):1531-54. PubMed ID: 23146067 [TBL] [Abstract][Full Text] [Related]
4. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378 [TBL] [Abstract][Full Text] [Related]
5. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
6. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. Ishima T; Fujita Y; Hashimoto K Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]
8. Antidepressant drugs use and epilepsy risk: A nationwide nested case-control study. Chu CS; Lee FL; Bai YM; Su TP; Tsai SJ; Chen TJ; Hsu JW; Chen MH; Liang CS Epilepsy Behav; 2023 Mar; 140():109102. PubMed ID: 36745964 [TBL] [Abstract][Full Text] [Related]
9. Fluoxetine versus other types of pharmacotherapy for depression. Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Sánchez C; Hyttel J Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421 [TBL] [Abstract][Full Text] [Related]
11. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating? Ribot R; Ouyang B; Kanner AM Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526 [TBL] [Abstract][Full Text] [Related]
12. Paroxetine versus other anti-depressive agents for depression. Purgato M; Papola D; Gastaldon C; Trespidi C; Magni LR; Rizzo C; Furukawa TA; Watanabe N; Cipriani A; Barbui C Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006531. PubMed ID: 24696195 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine versus other types of pharmacotherapy for depression. Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353 [TBL] [Abstract][Full Text] [Related]
15. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence. Kanner AM Epilepsy Behav; 2016 Aug; 61():282-286. PubMed ID: 27236241 [TBL] [Abstract][Full Text] [Related]
16. Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication. Tamblyn R; Bates DW; Buckeridge DL; Dixon WG; Girard N; Haas JS; Habib B; Iqbal U; Li J; Sheppard T J Am Geriatr Soc; 2020 Jul; 68(7):1494-1503. PubMed ID: 32181493 [TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277 [TBL] [Abstract][Full Text] [Related]
18. Citalopram versus other anti-depressive agents for depression. Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497 [TBL] [Abstract][Full Text] [Related]
19. Duloxetine versus other anti-depressive agents for depression. Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926 [TBL] [Abstract][Full Text] [Related]
20. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]